Amyloid is a protein that has misfolded and clumped together into insoluble fibrils the body cannot easily break down. The word covers a family of such deposits, but in aging and brain research it almost always means beta-amyloid, the fragment that collects between neurons and forms the plaques seen in Alzheimer’s brains. It is not confined to the head: transthyretin amyloid builds up in heart muscle in later life and is an underdiagnosed cause of heart failure. The entry Amyloid (beta-amyloid) covers the plaques, the amyloid hypothesis and how the protein became a biomarker.
What it measures
Amyloid is not a line on a routine blood panel. It is read three ways. An amyloid PET scan uses a radioactive tracer that binds fibrillar plaque, so the brain lights up where plaque has been laid down. Cerebrospinal fluid, taken by lumbar puncture, is tested for beta-amyloid 42 or, more reliably, its ratio to beta-amyloid 40; the level in fluid falls as plaque builds, because the protein is stuck in the brain rather than floating free. Blood tests are the newest route: plasma amyloid ratios and phosphorylated tau, especially p-tau217, track scan status closely enough to triage who needs further testing. Each test reports against a threshold validated for that specific tracer, assay and laboratory, so results do not transfer between platforms.
Typical values
| Test | How the result reads |
|---|---|
| Amyloid PET | Positive or negative, often also quantified on the centiloid scale, anchored so 0 is the average amyloid-negative young adult brain and 100 the average in mild to moderate Alzheimer’s dementia |
| Spinal fluid | Beta-amyloid 42, or the 42/40 ratio; a low value means more amyloid deposited in the brain |
| Blood | Amyloid ratio and p-tau217, usually reported as likely positive, indeterminate or likely negative rather than as a number to read yourself |
There is no universal cut-off. Positivity thresholds differ by tracer, assay and reference population, and each laboratory states its own.
Why it matters for longevity
Amyloid accumulates silently, beginning years and usually more than a decade before any memory complaint, which makes it the earliest measurable step in the most common cause of dementia. In older adults with normal cognition a positive scan is associated with higher risk of later decline, but it is a risk marker, not a diagnosis: many amyloid-positive people never develop dementia in their remaining lifetime. The signal is stronger further along, where amyloid status in people who already have Mild cognitive impairment (MCI) helps predict who progresses. The amyloid hypothesis, which holds that these deposits set the disease in motion, is supported but not sufficient on its own: plaque burden correlates only loosely with how impaired someone is, tau spread tracks symptoms better, and many autopsied brains carry heavy plaque with no dementia recorded in life. Antibody drugs that clear plaque do slow decline in early Alzheimer’s disease, modestly, at the cost of brain swelling and microbleeds in some patients.
What changes it
The two biggest drivers are outside your control: age, and the APOE gene variants you inherited, which shift how much amyloid you deposit and how early. Sleep is the lever with the clearest mechanism. During deep sleep the brain flushes metabolic waste, beta-amyloid among it, and short or fragmented sleep is associated with higher amyloid burden. Managing blood pressure and blood sugar from midlife, staying physically active and eating a Mediterranean or MIND-style pattern are associated with slower cognitive decline; the evidence that they lower amyloid specifically is much thinner. Nothing sold over a counter has been shown to clear plaque. The only agents that measurably remove it are prescription anti-amyloid antibodies, given by infusion, licensed for early symptomatic disease and requiring monitoring scans. If memory changes are new, persistent and interfering with daily tasks, see a clinician rather than order a test on your own.
Related reading
- How Sleep Affects Aging and How Much You Need
- How to Improve Sleep: A Practical Sleep Hygiene Protocol
- Shingles Vaccine Linked to Lower Dementia Risk
- How to Eat for Brain Health: A Cognitive Longevity Guide
Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.